-
CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to "Sell" Rating
来源: Buzz FX / 07 11月 2024 02:32:16 America/New_York
CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to "Sell" Rating Written by MarketBeat November 7, 2024 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) was upgraded by research analysts at S
Read more...